Estradiol is made through a chain of chemical conversions that starts with cholesterol in the human body, or with plant-derived sterols in pharmaceutical manufacturing. Whether your body is producing it naturally or a lab is synthesizing it for medication, the core process involves transforming a steroid backbone step by step until it becomes the most potent form of estrogen.
How Your Body Makes Estradiol
Every molecule of estradiol your body produces traces back to cholesterol. The conversion happens through a sequence of enzymatic steps, each one modifying the cholesterol molecule slightly until it becomes a functional estrogen. The process begins when an enzyme called P450scc (side chain cleavage) converts cholesterol into pregnenolone. Pregnenolone is then converted into progesterone. From there, progesterone is converted into androgens, including testosterone and androstenedione.
The final and most critical step is called aromatization. An enzyme called aromatase takes those androgens and converts them into estrogens. Specifically, aromatase converts testosterone into estradiol and androstenedione into estrone (a weaker estrogen). The aromatase reaction is a three-step oxidative process that breaks a carbon-carbon bond on the androgen molecule and reshapes the ring structure, releasing a small molecule of formic acid as a byproduct. This is the reaction that distinguishes estrogens from androgens at the molecular level.
Where Estradiol Is Produced in the Body
The ovaries are the primary production site in premenopausal women, specifically the granulosa cells of the ovarian follicles. In men and postmenopausal women, production shifts almost entirely to other tissues. The testes produce small amounts, but the real story is the wide network of tissues outside the gonads that can synthesize estradiol locally.
Fat tissue is the largest non-gonadal source of circulating estrogen in both men and women, and its contribution increases with age. Beyond fat, estradiol is also produced in the brain (by neurons and astrocytes in areas like the hippocampus and hypothalamus), the adrenal glands, bone cells, liver, skin, intestinal lining, and even blood vessel walls. These tissues contain the full set of enzymes needed to convert either circulating testosterone or cholesterol directly into estradiol. This local production matters because it allows tissues to regulate their own estrogen exposure independent of what the ovaries or testes are doing.
Normal blood levels reflect these production patterns. Premenopausal women typically have 10 to 300 pg/mL depending on the phase of their menstrual cycle, men run 20 to 50 pg/mL, and postmenopausal women fall below 10 pg/mL.
How Pharmaceutical Estradiol Is Made
The estradiol in medications is chemically identical to what the body produces, but it doesn’t come from human tissue or animal ovaries. It starts with plant sterols, compounds found in soybeans and wild yams that share a similar molecular backbone with cholesterol. Plants don’t make cholesterol themselves, but they produce related sterols like diosgenin that can serve as raw starting material.
The key distinction: diosgenin cannot be converted into steroid hormones by the human body. Eating yams or soy will not raise your estradiol levels. The conversion requires industrial chemical processing, specifically laboratory-based enzymatic steps that reshape the plant sterol molecule into bioidentical 17-beta estradiol. This involves stripping away side chains, adding specific functional groups, and precisely orienting the molecule so it fits human estrogen receptors.
The resulting compound is the active pharmaceutical ingredient, or API. From there, it can be formulated into different products. Estradiol valerate (sold as Progynova and others) is estradiol bonded to a valeric acid chain, which slows its absorption and extends its duration. Micronized estradiol hemihydrate (found in Femoston) is ground into tiny particles with a water molecule attached, which improves how readily it dissolves and absorbs. These aren’t different hormones. They’re the same estradiol molecule packaged differently to control how it enters the bloodstream.
How Delivery Route Affects the Final Product
The same estradiol compound behaves quite differently depending on how it enters the body. Oral tablets pass through the digestive system and liver before reaching general circulation, which reduces the amount that actually makes it into the bloodstream. Vaginal administration of micronized estradiol bypasses that digestive breakdown entirely, allowing direct absorption through the mucosa. Clinical data shows that vaginal administration of the same dose produces significantly higher blood estradiol levels and higher concentrations in uterine tissue compared to oral dosing.
This is why the same molecule gets manufactured into patches, gels, vaginal tablets, injections, and oral pills. Each delivery method is essentially a different engineering solution to the same problem: getting a fragile hormone molecule into circulation at a consistent, therapeutic level.
How Compounding Pharmacies Formulate Custom Doses
Compounding pharmacies create estradiol preparations by purchasing the pure active ingredient in bulk powder form from pharmaceutical wholesalers. From there, the compounder mixes it with inactive ingredients to create a specific dosage form: creams, troches, capsules, or sublingual tablets. The process is entirely compounder-specific, meaning the quality of the final product depends on the formulation recipe chosen, the equipment available, the skill of the pharmacist, and the cleanliness controls in the facility.
Two common compounded formulations combine multiple estrogens. Bi-est blends estradiol with estriol in varying ratios, while Tri-est adds estrone to that mix. These combinations aren’t available as standard FDA-approved products, which is the primary reason they’re compounded. Pellet formulations, which are implanted under the skin for slow release over months, require specialized manufacturing equipment typically found only in pharmaceutical production facilities rather than standard pharmacy settings.
The content and consistency of compounded preparations vary more than mass-manufactured pharmaceuticals because there is no single standardized manufacturing process. Each pharmacy follows its own master formulation record, and factors like ingredient sourcing, testing protocols, and environmental controls differ from one compounder to the next.